niacinamide has been researched along with Carcinoma, Papillary, Follicular in 2 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
Carcinoma, Papillary, Follicular: A thyroid neoplasm of mixed papillary and follicular arrangement. Its biological behavior and prognosis is the same as that of a papillary adenocarcinoma of the thyroid. (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1271)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sorafenib has clinically relevant antitumor activity in patients with progressive metastatic or locally advanced radio-iodine refractory differentiated thyroid cancer." | 6.77 | Long-term analysis of the efficacy and tolerability of sorafenib in advanced radio-iodine refractory differentiated thyroid carcinoma: final results of a phase II trial. ( Abdulrahman, RM; Corssmit, EP; Kapiteijn, E; Morreau, H; Schneider, TC; Smit, JW, 2012) |
| "Sorafenib has clinically relevant antitumor activity in patients with progressive metastatic or locally advanced radio-iodine refractory differentiated thyroid cancer." | 2.77 | Long-term analysis of the efficacy and tolerability of sorafenib in advanced radio-iodine refractory differentiated thyroid carcinoma: final results of a phase II trial. ( Abdulrahman, RM; Corssmit, EP; Kapiteijn, E; Morreau, H; Schneider, TC; Smit, JW, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dadu, R | 1 |
| Devine, C | 1 |
| Hernandez, M | 1 |
| Waguespack, SG | 1 |
| Busaidy, NL | 1 |
| Hu, MI | 1 |
| Jimenez, C | 1 |
| Habra, MA | 1 |
| Sellin, RV | 1 |
| Ying, AK | 1 |
| Cote, GJ | 1 |
| Sherman, SI | 1 |
| Cabanillas, ME | 1 |
| Schneider, TC | 1 |
| Abdulrahman, RM | 1 |
| Corssmit, EP | 1 |
| Morreau, H | 1 |
| Smit, JW | 1 |
| Kapiteijn, E | 1 |
1 trial available for niacinamide and Carcinoma, Papillary, Follicular
| Article | Year |
|---|---|
Long-term analysis of the efficacy and tolerability of sorafenib in advanced radio-iodine refractory differentiated thyroid carcinoma: final results of a phase II trial.
Topics: Adenocarcinoma, Follicular; Adenoma, Oxyphilic; Aged; Aged, 80 and over; Antineoplastic Agents; Benz | 2012 |
1 other study available for niacinamide and Carcinoma, Papillary, Follicular
| Article | Year |
|---|---|
Role of salvage targeted therapy in differentiated thyroid cancer patients who failed first-line sorafenib.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Papillary, Follicular; Chemo | 2014 |